Actively Recruiting
CT Quantitative Assessment of Interstitial Lung Disease
Led by Assiut University · Updated on 2025-05-01
70
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Interstitial lung disease (ILD) refers to a broad category of heterogeneous lung diseases with different etiologies and features characterized by inflammation and fibrosis of the lung parenchyma and manifested as exertional dyspnea, interstitial patterns on high resolution computed tomography (HRCT), and abnormal pulmonary function tests (PFTs) The aim of this study is to investigate is there any correlation between changes seen in the lung parenchyma by HRCT and the pulmonary functions of the patients.
CONDITIONS
Official Title
CT Quantitative Assessment of Interstitial Lung Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of interstitial lung disease based on clinical, radiological, and pulmonary function criteria, with or without histopathological confirmation
- Availability of CT chest DICOM images and pulmonary function test results taken within two weeks of each other
You will not qualify if you...
- Pregnancy
- Pulmonary edema
- Primary pulmonary hypertension
- Chronic obstructive pulmonary disease
- Congestive heart failure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assiut University Hospital
Asyut, Asyut Governorate, Egypt, 71515
Actively Recruiting
Research Team
R
Ramy M Ahmed, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here